Revolutionizing Cancer Treatment
with Circulating Cell Capture
Preventing Metastasis by Removing Circulating Tumor Cells
.
At Captec, we’re proud to introduce a groundbreaking solution to one of cancer’s deadliest challenges: metastasis. Our CAPTEC Cartridge is an innovative prototype designed to capture and remove circulating tumor cells (CTCs) from the bloodstream, reducing the risk of cancer spread. After extensive research, we have developed a functional prototype and are now rapidly advancing towards commercializing this life-saving product.
Backed by a world-class team of scientists, medical innovators, and industry veterans, we’re on the cusp of bringing a revolutionary cancer treatment to the market.
Discover how our prototype is leading the way in cancer treatment.
Our Mission
Captec’s mission is to prevent cancer metastasis by creating innovative solutions that remove circulating tumor cells (CTCs) from the bloodstream. With a prototype already developed, we are actively working on the final stages of product validation to bring this solution to the global oncology market. We are committed to saving lives by preventing the spread of cancer, the leading cause of cancer-related deaths.
Paul Stolk
Andrass Guttmann
Our Team
Captec is driven by a team of experienced professionals who are transforming cancer care through their combined expertise in science, medicine, and business.
Supported by a strong board of scientific advisors, including prominent oncologists and bioengineers, the Captec team is positioned to transform cancer treatment.
Our Team
Captec is driven by a team of experienced professionals who are transforming cancer care through their combined expertise in science, medicine, and business. Supported by a strong board of scientific advisors, including prominent oncologists and bioengineers, the Captec team is positioned to transform cancer treatment.
Paul Stolk
Andrass Guttmann
Gabor Jarvas
Johan De Jonghe
Gabor Jarvas
Johan De Jonghe
The Solution: Prototype in Action
Our Breakthrough:
Captec has developed a functional prototype of the CAPTEC Cartridge, a device that works to capture and filter out circulating tumor cells (CTCs) from the blood. After years of research and development, this technology has successfully passed the prototype stage and is now in the final phases of testing and regulatory preparation.
The CAPTEC Cartridge is designed for use alongside existing hemoperfusion systems, making it both effective and easy to integrate into current medical practices. By removing CTCs, we’re addressing the root cause of metastasis, which accounts for 90% of cancer-related deaths.
Why This Matters:
Cancer patients undergoing surgery, chemotherapy, or other treatments are at constant risk of CTC-induced metastasis. While current treatments often target tumors, metastasis remains a leading cause of cancer recurrence and patient mortality. Captec’s solution aims to change this by directly targeting the circulating cells responsible for spreading cancer throughout the body.
The Need for Innovation
Cancer Metastasis: The Biggest Unmet Need in Oncology
Despite advancements in cancer treatments, metastasis remains the primary cause of cancer-related deaths. Traditional therapies like chemotherapy often fail to prevent metastasis, and in some cases, surgery can even trigger the release of CTCs into the bloodstream.
This is where Captec’s technology steps in. We have developed a solution that directly addresses the unmet need of stopping cancer metastasis before it can take hold. With millions of cancer surgeries performed each year globally, there is a critical need for an effective product that can prevent cancer from spreading.
A Proven Prototype:
Our CAPTEC Cartridge prototype has shown promising results in early-stage testing, capturing up to 99% of CTCsfrom the bloodstream. With the prototype now in place, we are conducting the final clinical trials and regulatory submissions to bring this much-needed product to patients.
Our Vision for the Future
From Prototype to Product:
The CAPTEC Cartridge is more than just an idea—it’s a working prototype. Our vision is to take this prototype through the final stages of clinical validation, achieve regulatory approval, and bring it to market where it can save lives. We’re not starting from scratch; we’ve already developed the solution. Now, we’re moving swiftly to make it available to patients worldwide.
Collaborative Innovation
Our commitment to innovation doesn’t end with our prototype. We are actively collaborating with leading hospitals and research institutions to continuously improve our product, ensuring that the CAPTEC Cartridge becomes a cornerstone in the fight against metastasis.
Join Us !
Captec invites partners, investors, and medical professionals to join us in bringing this life-changing technology to the forefront of cancer care. With a functional prototype and a clear path to market, we are closer than ever to making metastasis prevention a reality for cancer patients.
